DCM
DAFNA Capital Management Portfolio holdings
AUM
$362M
This Quarter Return
+56.7%
1 Year Return
-0.48%
3 Year Return
+117.01%
5 Year Return
+181.93%
10 Year Return
+1,483.26%
AUM
$347M
AUM Growth
+$347M
(+45%)
Cap. Flow
+$1.2M
Cap. Flow
% of AUM
0.35%
Top 10 Holdings %
Top 10 Hldgs %
48.52%
Holding
96
New
16
Increased
10
Reduced
35
Closed
8
Top Buys
| 1 |
IMMU
Immunomedics Inc
IMMU
|
$8.89M |
| 2 |
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
|
$7.79M |
| 3 |
Syndax Pharmaceuticals
SNDX
|
$5.34M |
| 4 |
CNST
Constellation Pharmaceuticals, Inc.
CNST
|
$5.14M |
| 5 |
Liquidia Corp
LQDA
|
$4.63M |
Top Sells
| 1 |
Corbus Pharmaceuticals
CRBP
|
$5.37M |
| 2 |
DexCom
DXCM
|
$4.95M |
| 3 |
AtriCure
ATRC
|
$4.79M |
| 4 |
Compugen
CGEN
|
$3.86M |
| 5 |
Mersana Therapeutics
MRSN
|
$3.08M |
Sector Composition
| 1 | Healthcare | 88.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Stereotaxis
STXS
$261M
| $61M | 17.61% | 13,680,554 | – | – |
|
|
BPMC
2
DELISTED
Blueprint Medicines
BPMC
| $17.8M | 5.13% | 228,089 | – | – |
|
3
Fate Therapeutics
FATE
$120M
| $16.8M | 4.86% | 490,861 +20,861 | +4% | +$716K |
|
|
ARNA
4
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $15.4M | 4.45% | 245,142 +65,500 | +36% | +$4.12M |
|
|
DRNA
5
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $11.5M | 3.33% | 454,236 +306,522 | +208% | +$7.79M |
|
6
Akebia Therapeutics
AKBA
$833M
| $10.4M | 2.99% | 762,666 -90,872 | -11% | -$1.23M |
|
7
Neurocrine Biosciences
NBIX
$13.8B
| $8.93M | 2.58% | 73,208 -7,000 | -9% | -$854K |
|
|
IMMU
8
DELISTED
Immunomedics Inc
IMMU
| $8.89M | 2.57% | +250,905 | New | +$8.89M |
|
9
Galapagos
GLPG
$2.07B
| $8.76M | 2.53% | 44,375 -2,000 | -4% | -$395K |
|
|
10
DexCom
DXCM
$29.5B
| $8.57M | 2.47% | 21,138 -12,200 | -37% | -$4.95M |
|
11
ProQR Therapeutics
PRQR
$237M
| $7.52M | 2.17% | 1,237,400 | – | – |
|
12
iShares Biotechnology ETF
IBB
$5.6B
| $7.5M | 2.17% | 54,900 -18,000 | -25% | -$2.46M |
|
13
Arcturus Therapeutics
ARCT
$462M
| $6.97M | 2.01% | 149,017 +96,431 | +183% | +$4.51M |
|
|
SAGE
14
DELISTED
Sage Therapeutics
SAGE
| $6.87M | 1.98% | 165,306 | – | – |
|
|
AGTC
15
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $6.43M | 1.86% | 1,160,878 | – | – |
|
|
BHVN
16
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $6.4M | 1.85% | 87,600 -3,000 | -3% | -$219K |
|
|
TVRD
17
Tvardi Therapeutics, Inc. Common Stock
TVRD
$281M
| $6.35M | 1.83% | 371,033 | – | – |
|
|
18
Mersana Therapeutics
MRSN
$36.5M
| $6.32M | 1.82% | 270,163 -131,456 | -33% | -$3.08M |
|
|
19
AtriCure
ATRC
$1.84B
| $5.99M | 1.73% | 133,229 -106,500 | -44% | -$4.79M |
|
|
20
Syndax Pharmaceuticals
SNDX
$1.41B
| $5.34M | 1.54% | +360,000 | New | +$5.34M |
|
|
21
Compugen
CGEN
$132M
| $5.15M | 1.49% | 343,046 -256,954 | -43% | -$3.86M |
|
|
CNST
22
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $5.14M | 1.48% | +170,942 | New | +$5.14M |
|
|
LMNX
23
DELISTED
Luminex Corp
LMNX
| $5.01M | 1.45% | 154,091 -50,000 | -24% | -$1.63M |
|
24
Kura Oncology
KURA
$686M
| $4.8M | 1.38% | 294,260 -13,281 | -4% | -$216K |
|
|
CSII
25
DELISTED
Cardiovascular Systems, Inc.
CSII
| $4.77M | 1.38% | 151,200 +100,000 | +195% | +$3.15M |
|